These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11161841

  • 1. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B, Shi Y, Zou M, Farid NR.
    Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
    [Abstract] [Full Text] [Related]

  • 2. P53 mutations in thyroid carcinoma: tidings from an old foe.
    Farid NR.
    J Endocrinol Invest; 2001 Feb; 24(7):536-45. PubMed ID: 11508790
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA.
    Oncogene; 1996 Aug 15; 13(4):687-93. PubMed ID: 8761289
    [Abstract] [Full Text] [Related]

  • 4. Methylation and repeats in silent and nonsense mutations of p53.
    Kouidou S, Malousi A, Maglaveras N.
    Mutat Res; 2006 Jul 25; 599(1-2):167-77. PubMed ID: 16620878
    [Abstract] [Full Text] [Related]

  • 5. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
    De Benedetti VM, Travis LB, Welsh JA, van Leeuwen FE, Stovall M, Clarke EA, Boice JD, Bennett WP.
    Cancer Epidemiol Biomarkers Prev; 1996 Feb 25; 5(2):93-8. PubMed ID: 8850268
    [Abstract] [Full Text] [Related]

  • 6. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
    Kouidou S, Malousi A, Kyventidis A, Fragou A, Maglaveras N.
    Breast Cancer Res Treat; 2007 Dec 25; 106(3):351-60. PubMed ID: 17505880
    [Abstract] [Full Text] [Related]

  • 7. Genetic mutations in thyroid carcinoma.
    Taccaliti A, Boscaro M.
    Minerva Endocrinol; 2009 Mar 25; 34(1):11-28. PubMed ID: 19209125
    [Abstract] [Full Text] [Related]

  • 8. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.
    Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N, Akiyama M.
    Cancer Res; 1992 Mar 01; 52(5):1369-71. PubMed ID: 1737400
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic pathways of two types of gastric cancer.
    Tahara E.
    IARC Sci Publ; 2004 Mar 01; (157):327-49. PubMed ID: 15055305
    [Abstract] [Full Text] [Related]

  • 18. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
    van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH.
    J Pathol; 1999 Dec 01; 189(4):504-13. PubMed ID: 10629550
    [Abstract] [Full Text] [Related]

  • 19. [Unique association of p53 mutations with undifferentiated carcinoma of the thyroid].
    Ito T, Seyama T, Hayashi Y, Dohi K, Akiyama M.
    Nihon Rinsho; 1994 Apr 01; 52(4):1069-74. PubMed ID: 8196165
    [Abstract] [Full Text] [Related]

  • 20. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.
    J Urol; 2003 Apr 01; 169(4):1219-28. PubMed ID: 12629332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.